Bicara Therapeutics BCAX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$3.12M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 42.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 15.81% to 14.90% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Franklin Resources | Mutual Fund | 2026/Q3 | +713,245 | 4.0% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +195,191 | 1.0% |
| Citigroup Inc. | Public Company | 2026/Q3 | +142,329 | 0.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +97,404 | 5.9% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +82,279 | 0.1% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +67,946 | 0.2% |
| Tema ETFs LLC | Mutual Fund | 2026/Q3 | +38,259 | 0.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +90,637 | 0.1% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,004,383 | 5.8% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +828,979 | 1.5% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +629,532 | 3.1% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +539,405 | 3.8% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +352,463 | 0.7% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +346,166 | 2.9% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +331,729 | 1.8% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 20 Oct 2026 | David Raben | Former Chief Medical Officer | Intent to Sell (Form 144) | -24,777 | $18.12 | – |
| 7 Sep 2026 | Ryan Cohlhepp | President | Derivative Exercise and Sale | -17,500 | $23.43 | 181,641 |
| 7 Sep 2026 | Ivan Hyep | Former Chief Financial Officer | Intent to Sell (Form 144) | -12,500 | $22.64 | – |
| 9 Aug 2026 | Ryan Cohlhepp | President | Derivative Exercise and Sale | -18,750 | $27.98 | 181,641 |
| 9 Aug 2026 | Claire Mazumdar Clemon | Chief Executive Officer | Derivative Exercise and Sale | -10,000 | $27.98 | 362,152 |
| 9 Aug 2026 | Ivan Hyep | Former Chief Financial Officer | Derivative Exercise and Sale | -12,500 | $27.97 | 129,855 |
| 27 Jul 2026 | Christy Oliger | Independent Director | Other Derivative Acquisition | +38,950 | $26.88 | 38,950 |
| 27 Jul 2026 | Jeremy Bender | Independent Director | Other Derivative Acquisition | +38,950 | $26.88 | 38,950 |
| 9 Jul 2026 | Claire Mazumdar Clemon | Chief Executive Officer | Derivative Exercise and Sale | -10,000 | $29.68 | 362,152 |
| 8 Jul 2026 | Ryan Cohlhepp | President | Automatic Disposition | -10,000 | $30.35 | 181,641 |
| 7 Jul 2026 | Ryan Cohlhepp | President | Derivative Exercise and Sale | -18,750 | $28.76 | 181,641 |
| 7 Jul 2026 | David Raben | Former Chief Medical Officer | Intent to Sell (Form 144) | -50,000 | $28.56 | – |
| 7 Jul 2026 | Ivan Hyep | Former Chief Financial Officer | Automatic Disposition | -15,500 | $30.31 | 129,855 |
| 7 Jul 2026 | Ivan Hyep | Former Chief Financial Officer | Derivative Exercise and Sale | -12,500 | $28.60 | 129,855 |
| 24 Jun 2026 | David Raben | Former Chief Medical Officer | Intent to Sell (Form 144) | -50,000 | $26.49 | – |
| 8 Jun 2026 | Michael Powell | Independent Chairperson | Other Derivative Acquisition | +19,475 | $20.56 | 19,475 |
| 8 Jun 2026 | Kiran Mazumdar-Shaw | Former Independent Director | Other Derivative Acquisition | +19,475 | $20.56 | 19,475 |
| 8 Jun 2026 | RA Capital Management, L.P. | Other Derivative Acquisition | +19,475 | $20.56 | 19,475 | |
| 8 Jun 2026 | Scott Robertson | Independent Director | Other Derivative Acquisition | +19,475 | $20.56 | 19,475 |
| 8 Jun 2026 | Christopher Bowden | Independent Director | Other Derivative Acquisition | +19,475 | $20.56 | 19,475 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 9,861,807 | 14.9% | 3.8 |
| 15 Oct 2026 | 10,298,207 | 15.6% | 11.5 |
| 30 Sep 2026 | 10,693,490 | 16.2% | 14.2 |
| 15 Sep 2026 | 11,191,724 | 16.9% | 22.6 |
| 31 Aug 2026 | 10,845,514 | 16.4% | 22.1 |
| 14 Aug 2026 | 10,463,188 | 15.8% | 13.3 |
No comments yet — be the first to weigh in on BCAX.
Sign in to join the discussion.